对乙酰氨基酚在导管球囊置入促宫颈成熟前应用——一项随机对照试验
初产妇足月因医学指征引产,随机接受静脉对乙酰氨基酚1克(N=71)或安慰剂(N=70)后置入导管球囊。对乙酰氨基酚组平均VAS总分更低(4.39 vs 5.37,P=.045),平均VAS<5比例更高(65.2% vs 44.1%,P=.016),置入后不活动比例更低(33.8% vs 50.0%,P=.037),需镇痛药比例更低(31.3% vs 66.1%,P<.001),但产妇满意度无显著差异。
要点
- 对乙酰氨基酚组平均VAS总分低于安慰剂组(4.39 vs 5.37,P=.045)。
- 对乙酰氨基酚组平均VAS<5比例高于安慰剂组(65.2% vs 44.1%,P=.016)。
- 对乙酰氨基酚组置入后不活动(33.8% vs 50.0%)和需镇痛药(31.3% vs 66.1%)比例更低。
核心结论
- 与安慰剂相比,导管球囊置入前给予对乙酰氨基酚与更低的VAS评分、更少的镇痛药使用和产妇不活动相关。
研究设计与样本
- 随机对照试验,初产妇足月因医学指征引产,随机接受静脉对乙酰氨基酚1克(N=71)或安慰剂(N=70)后置入导管球囊,产妇对分组设盲。
主要发现
- 置入后2、30、60分钟中位VAS评分两组相当:6.46±2.77 vs 6.66±2.78,P=.68;5.53±3.20 vs 5.93±3.01,P=.46;5.83±3.25 vs 6.49±2.88,P=.26。
- 对乙酰氨基酚组平均VAS总分低于安慰剂组(4.39 vs 5.37,P=.045),平均VAS<5比例高于安慰剂组(65.2% vs 44.1%,P=.016)。
- 多因素logistic回归校正产妇年龄后差异持续(OR=2.2,95%CI 1.1-4.5,P=.036)。
- 置入后对乙酰氨基酚组不活动比例低于安慰剂组(33.8% vs 50.0%,P=.037),需镇痛药比例低于安慰剂组(31.3% vs 66.1%,P<.001)。
- 产妇满意度评分两组相似(P=.877);宫颈成熟、导管置入至分娩时间及产程和新生儿结局两组无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Assessing maternal pain and satisfaction following administration of paracetamol vs. placebo prior to catheter balloon placement. METHODS: Primiparous women at term admitted for medically-indicated labor induction were randomized to receive intravenous paracetamol 1 gram in 100cc normal saline (N=71) or placebo of 100cc normal saline (N=70) prior to catheter balloon insertion. The women were blinded to the intervention allocation. Primary outcomes were visual analog scale (VAS) scores and maternal satisfaction, assessed via questionnaire. RESULTS: Pre-induction maternal pain did not differ between the paracetamol and placebo groups. Median VAS scores at 2, 30, and 60 minutes after catheter insertion were comparable between the groups: 6.46±2.77 vs. 6.66±2.78, P=.68; 5.53±3.20 vs. 5.93±3.01, P=.46; and 5.83±3.25 vs. 6.49±2.88, P=.26, respectively. For the paracetamol vs. placebo group, the mean sum of VAS scores was lower (4.39 vs. 5.37, P=.045) and the proportion with a mean VAS score <5 was higher (65.2% vs. 44.1%, P=.016). This difference persisted in a multivariate logistic regression analysis adjusted for maternal age (OR=2.2, 95% CI 1.1-4.5, P=.036). After balloon insertion, relatively fewer women in the paracetamol vs. placebo group showed immobility (33.8% vs 50.0%, P=.037) and needed analgesics (31.3% vs. 66.1%, P<.001). Maternal satisfaction score was similar between the groups (P=.877). Cervical ripening, duration from catheter insertion to delivery, and labor and neonatal outcomes did not differ significantly between the groups. CONCLUSIONS: The administration of paracetamol compared with placebo prior to catheter balloon insertion was associated with lower VAS score and less analgesic use and maternal immobility. El resumen está disponible en Español al final del artículo.
引用
- Frank Wolf M, Sgayer I, Abu Shqara R, et al. Paracetamol prior to catheter balloon insertion for labor induction-A randomized controlled trial. Am J Obstet Gynecol MFM. 2025. PMID: 39848492. doi:10.1016/j.ajogmf.2025.101610
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。